3-Bromo-5-(3-chlorophenoxy)pyridine

Catalog No.: 
ACGGQO822
CAS No.: 
28232-65-7
Molecular Formula: 
C11H7BrClNO
Molecular Weight: 
284.54
3-Bromo-5-(3-chlorophenoxy)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$461.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-Bromo-5-(3-chlorophenoxy)pyridine
IUPAC Name3-Bromo-5-(3-chlorophenoxy)pyridine
Molecular FormulaC11H7BrClNO
Molecular Weight284.54
SMILESClC1=CC(OC2=CN=CC(Br)=C2)=CC=C1
InChI KeyNAWCDQFYAZDWIX-UHFFFAOYSA-N
Synonym3-Bromo-5-(3-chlorophenoxy)pyridine;3-(3-chlorophenoxy)-5-bromopyridine;3-(3-Chlorphenoxy)-5-broMpyridin;Pyridine, 3-broMo-5-(3-chlorophenoxy)-
CAS No.28232-65-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACGGQO822 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHZYR128 route compound structure diagram
    ACHZYR128625-92-3In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGGQO822 route product structure diagram
    ACGGQO82228232-65-7
Inquiry

2. ACGGQO822 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDWYZ195 route compound structure diagram
    ACDWYZ195407-20-5In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGGQO822 route product structure diagram
    ACGGQO82228232-65-7
Inquiry

3. ACGGQO822 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGGQO822 route product structure diagram
    ACGGQO82228232-65-7
Inquiry

Comments (0)